These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26243434)

  • 1. "Sundowning" as a biological phenomenon: current understandings and future directions: an update.
    Gnanasekaran G
    Aging Clin Exp Res; 2016 Jun; 28(3):383-92. PubMed ID: 26243434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Sundowning" and other temporally associated agitation states in dementia patients.
    Bachman D; Rabins P
    Annu Rev Med; 2006; 57():499-511. PubMed ID: 16409163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sundowning syndrome in aging and dementia: research in mouse models.
    Bedrosian TA; Nelson RJ
    Exp Neurol; 2013 May; 243():67-73. PubMed ID: 22627081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of sundowning. A selective review of pharmacological and nonpharmacological studies.
    McGaffigan S; Bliwise DL
    Drugs Aging; 1997 Jan; 10(1):10-7. PubMed ID: 9111704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sundowning syndrome: a possible marker of frailty in Alzheimer's disease?
    Ferrazzoli D; Sica F; Sancesario G
    CNS Neurol Disord Drug Targets; 2013 Jun; 12(4):525-8. PubMed ID: 23574165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tackling sundowning in a patient with Alzheimer's disease.
    Sharer J
    Medsurg Nurs; 2008 Feb; 17(1):27-9. PubMed ID: 18429537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review.
    de Jonghe A; Korevaar JC; van Munster BC; de Rooij SE
    Int J Geriatr Psychiatry; 2010 Dec; 25(12):1201-8. PubMed ID: 21086534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calming dementia-related agitation.
    Johns Hopkins Med Lett Health After 50; 2007 Sep; 19(7):4-5. PubMed ID: 18229401
    [No Abstract]   [Full Text] [Related]  

  • 9. Bright light treatment of behavioral and sleep disturbances in patients with Alzheimer's disease.
    Satlin A; Volicer L; Ross V; Herz L; Campbell S
    Am J Psychiatry; 1992 Aug; 149(8):1028-32. PubMed ID: 1353313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of behavioral disturbances and psychosis associated with dementia.
    Lochhead JD; Nelson MA; Maguire GA
    Psychiatr Pol; 2016; 50(2):311-22. PubMed ID: 27288676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for the management of agitation in dementia.
    Howard R; Ballard C; O'Brien J; Burns A;
    Int J Geriatr Psychiatry; 2001 Jul; 16(7):714-7. PubMed ID: 11466751
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience.
    Kindermann SS; Dolder CR; Bailey A; Katz IR; Jeste DV
    Drugs Aging; 2002; 19(4):257-76. PubMed ID: 12038878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.
    Raskind MA; Wang LY
    Int Psychogeriatr; 2014 Jun; 26(6):879-83. PubMed ID: 24703502
    [No Abstract]   [Full Text] [Related]  

  • 14. Sundowning in Patients with Dementia: Identification, Prevalence, and Clinical Correlates.
    Toccaceli Blasi M; Valletta M; Trebbastoni A; D'Antonio F; Talarico G; Campanelli A; Sepe Monti M; Salati E; Gasparini M; Buscarnera S; Salzillo M; Canevelli M; Bruno G
    J Alzheimers Dis; 2023; 94(2):601-610. PubMed ID: 37334595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dementia update. Pharmacologic management of agitation and psychosis in older demented patients.
    Zaraa AS
    Geriatrics; 2003 Oct; 58(10):48-50, 52-3. PubMed ID: 14569642
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of rest-activity disorders in dementia and special focus on sundowning.
    Staedt J; Stoppe G
    Int J Geriatr Psychiatry; 2005 Jun; 20(6):507-11. PubMed ID: 15920710
    [No Abstract]   [Full Text] [Related]  

  • 17. Electroconvulsive therapy (ECT) for treating agitation in dementia (major neurocognitive disorder) - a promising option.
    Glass OM; Forester BP; Hermida AP
    Int Psychogeriatr; 2017 May; 29(5):717-726. PubMed ID: 28095946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of agitation in patients with dementia.
    Mintzer JE; Hoernig KS; Mirski DF
    Clin Geriatr Med; 1998 Feb; 14(1):147-75. PubMed ID: 9456340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of agitation in dementia patients].
    González Salvador MT; Arango López C; Lyketsos CG
    Med Clin (Barc); 1999 Nov; 113(15):592-7. PubMed ID: 10605687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.